(Q33844438)

29 July 2017

Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis (English)

1 reference

29 July 2017

9

Yasuyuki Ishibashi

1 reference

29 July 2017

Seiya Ota

1

1 reference

29 July 2017

Ryo Inoue

2

1 reference

29 July 2017

Takashi Shiozaki

3

1 reference

29 July 2017

Yuji Yamamoto

4

1 reference

29 July 2017

Naoki Hashimoto

5

1 reference

29 July 2017

On Takeda

6

1 reference

29 July 2017

Kei Yoshikawa

7

1 reference

29 July 2017

Junji Ito

8

1 reference

29 July 2017

10 December 2016

1 reference

29 July 2017

1 reference

29 July 2017

24

1 reference

29 July 2017

4

1 reference

29 July 2017

601-607

1 reference

Creative Commons Attribution 4.0 International

29 July 2017

start time

10 December 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s12282-016-0746-8

0 references

cites work

Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5487871

Atypical femoral fractures bilaterally in a patient receiving denosumab

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5487871

Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5487871

Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5487871

Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5487871

Bisphosphonates in oncology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5487871

Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5487871

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5487871

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5487871

Severely suppressed bone turnover: a potential complication of alendronate therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5487871

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research

5 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-016-0746-8

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-016-0746-8

Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-016-0746-8

Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-016-0746-8

Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-016-0746-8

Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-016-0746-8

Prophylactic nailing of incomplete atypical femoral fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-016-0746-8

Bisphosphonate Use and Atypical Fractures of the Femoral Shaft

21 January 2018

1 reference

12 December 2020

Definition and classification of fracture non-unions

1 reference

12 December 2020

Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy

1 reference

12 December 2020

Treatment of femoral fracture nonunion after long-term bisphosphonate use

1 reference

12 December 2020

Atypical femoral fracture in a patient treated with denosumab

1 reference

12 December 2020

10.1007/S12282-016-0746-8

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference